Larger putamen in individuals at risk and with manifest bipolar disorder.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Thomas-Odenthal Florian, Stein Frederike, Vogelbacher Christoph, Alexander Nina, Bechdolf Andreas, Bermpohl Felix, Bröckel Kyra, Brosch Katharina, Correll Christoph U, Evermann Ulrika, Falkenberg Irina, Fallgatter Andreas, Flinkenflügel Kira, Grotegerd Dominik, Hahn Tim, Hautzinger Martin, Jansen Andreas, Juckel Georg, Krug Axel, Lambert Martin, Leicht Gregor, Leopold Karolina, Meinert Susanne, Mikolas Pavol, Mulert Christoph, Nenadić Igor, Pfarr Julia-Katharina, Reif Andreas, Ringwald Kai, Ritter Philipp, Stamm Thomas, Straube Benjamin, Teutenberg Lea, Thiel Katharina, Usemann Paula, Winter Alexandra, Wroblewski Adrian, Dannlowski Udo, Bauer Michael, Pfennig Andrea, Kircher Tilo
Аннотация
METHODS: In 410 male and female participants aged 17-35 years, we compared gray matter volume (3T MRI) between individuals at risk for BD (as assessed using the EPIbipolar scale; n = 208), patients with a DSM-IV-TR diagnosis of BD (n = 87), and healthy controls (n = 115) using voxel-based morphometry in SPM12/CAT12. We applied conjunction analyses to identify similarities in gray matter volume alterations in individuals at risk and BD patients, relative to healthy controls. We also performed exploratory whole-brain analyses to identify differences in gray matter volume among groups. ComBat was used to harmonize imaging data from seven sites.
RESULTS: Both individuals at risk and BD patients showed larger volumes in the right putamen than healthy controls. Furthermore, individuals at risk had smaller volumes in the right inferior occipital gyrus, and BD patients had larger volumes in the left precuneus, compared to healthy controls. These findings were independent of course of illness (number of lifetime manic and depressive episodes, number of hospitalizations), comorbid diagnoses (major depressive disorder, attention-deficit hyperactivity disorder, anxiety disorder, eating disorder), familial risk, current disease severity (global functioning, remission status), and current medication intake.
CONCLUSIONS: Our findings indicate that alterations in the right putamen might constitute a vulnerability marker for BD.